Related Experiment Video
Updated: Dec 24, 2025

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents
Abdolrasoul Soleimani1, Francisco Martínez, Vasiliki Economopoulos
1Department of Chemical and Biochemical Engineering, The University of Western Ontario, 1151 Richmond St., London, Canada. egillie@uwo.ca.
Abstract:
Polymer cross-linking was explored as an approach for increasing the relaxivity of macromolecular contrast agents for magnetic resonance imaging. Poly(ethylene glycol) methyl ether methacrylate, N-(2-aminoethyl)methacrylamide hydrochloride, and the cross-linker ethylene glycol dimethacrylate were copolymerized under free radical conditions. By tuning the cross-linker content and reaction concentration, it was possible to obtain 10 nm nanogels in a single synthetic step. The pendant amine moieties were functionalized with an isothiocyanate derivative of diethylenetriaminepentaacetic acid (DTPA) and Gd(iii) was chelated. In comparison with a linear control polymer prepared under the same conditions in the absence of the cross-linking agent, the nanogel contrast agent did exhibit enhanced relaxivity with an r1 of 20.8 ± 0.2 at 20 MHz and 17.5 ± 0.4 at 60 MHz (corresponding to the clinical field strength of 1.5 T). The nuclear magnetic resonance dispersion profile was modeled to demonstrate that the enhanced relaxivity was a result of the nanogel agent's increased rotational correlation time, that is proposed to result from the constraint on motion imparted by the cross-linking. T1 weighted imaging in mice showed enhanced contrast and vascular circulation for the nanogel relative to Gd(iii)-DTPA (Magnevist) demonstrating the future promise of these new agents.
More Related Videos
13:21Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
14:01Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011